News
CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering ...
6h
MarketBeat on MSNIs It Time to Buy the Dip in Novo Nordisk Stock?CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...
StockStory.org on MSN20h
CVS Q1 Earnings Call: Guidance Raised Amid Segment Shifts and Pharmacy InnovationDiversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.
CVS Health's stock price received a positive prognosis from Truist Financial, boosting the target from $82 to $84. The ...
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), IBM Corp. (IBM) and ...
Bristol Myers CEO Christopher Boerner advocates global cost-sharing for drug R&D and criticizes PBMs. Read nore here.
The fund posted a return of 4.45% (Class I shares) for the first quarter of 2025. Stock selection in the health care sector, ...
Bristol Myers Squibb President Benjamin Hickey recently cashed out a modest $3,701 in stock, barely enough for a luxury ...
237.40. On previous day, the Marksans Pharma Share Price (NSE) closed at Rs. 226.23, featuring among the most traded securities on the National Stock Exchange.
10.88. On previous day, the Vista Pharma Share Price (NSE) closed at Rs. 10.45, featuring among the most traded securities on the National Stock Exchange.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results